In Vivo Evaluation of Sepigel-Based Meglumine Antimoniate and Amphotericin B for Cutaneous Leishmani...
In Vivo Evaluation of Sepigel-Based Meglumine Antimoniate and Amphotericin B for Cutaneous Leishmaniasis Treatment
About this item
Full title
Author / Creator
López-Arencibia, Atteneri , Bethencourt-Estrella, Carlos J , Berenguer, Diana , Domínguez-de-Barros, Angélica , Alcover, M Magdalena , Sessa, Marcella , Halbaut, Lyda , Fisa, Roser , Calpena-Campmany, Ana Cristina , Córdoba-Lanús, A Elizabeth , Lorenzo-Morales, Jacob , Riera, Cristina and Piñero, José E
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Cutaneous leishmaniasis (CL) poses a significant public health concern in endemic regions due to its increasing prevalence and substantial impact on affected individuals. This disease is primarily caused by the
protozoa, which are transmitted through insect bites, and it manifests as a range of symptoms, from self-healing lesions to severe disfi...
Alternative Titles
Full title
In Vivo Evaluation of Sepigel-Based Meglumine Antimoniate and Amphotericin B for Cutaneous Leishmaniasis Treatment
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8becab78c2964a6e97ae51166edba6d0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8becab78c2964a6e97ae51166edba6d0
Other Identifiers
ISSN
2076-0817
E-ISSN
2076-0817
DOI
10.3390/pathogens13080712
